Table 2 Hemodynamic data
From: Effects of propofol and sevoflurane on hepatic blood flow: a randomized controlled trial
|  | Propofol Group (n = 9) | Sevoflurane Group (n = 9) | Between group difference | |
|---|---|---|---|---|
MAP (mmHg) | T1 | 82 (9) | 69 (10) | 13 [4–22]a |
T2 | 76 (5) | 74 (9) | 1 [−7–9] | |
T3 | 82 (5) | 76 (9) | 6 [−2–13] | |
HR (bpm) | T1 | 75 (12) | 78 (14) | -2 [− 19–14] |
T2 | 79 (10) | 80 (11) | -1 [− 15–13] | |
T3 | 77 (8) | 79 (12) | -2 [−16–11] | |
CVP (mmHg) | T1 | 5 (2) | 5 (2) | 0 [−2–2] |
T2 | 5 (1) | 5 (4) | -1 [−4–2] | |
T3 | 4 (2) | 6 (2) | -2 [−4–1] | |
CI (L.min−1.m−2) | T1 | 2.7 (0.4) | 3.1 (0.8) | −0.3 [−1.1–0.4] |
T2 | 3.0 (0.5) | 3.3 (0.6) | −0.3 [−1–0.4] | |
T3 | 3.0 (0.4) | 3.2 (0.6) | −0.2 [− 0.9–0.4] | |
SVR (dyn.sec.cm− 5) | T1 | 1267 (231) | 991 (230) | 276 [−52–604] |
T2 | 1084 (209) | 1000 (316) | 84 [−301–469] | |
T3 | 1168 (178) | 1031 (261) | 136 [−166–439] | |
PPV (%) | T1 | 9 (4.0) | 8 (4.6) | 1.2 [−3.6–6.1] |
T2 | 9 (1.7) | 10 (5.6) | −0.9 [−4.9–3.1] | |
T3 | 8 (3.0) | 8 (5.8) | 0.1 [−3.9–4.1] | |
Lactacte (mg.dL−1) | T1 | 8.9 (1.5) | 12.2 (3.8) | −3.3 [− 6.0 – − 0.6]a |
T2 | 10.1 (2.7)b | 16.3 (6.8)b | −6.2 [− 10.9 – − 1.6]a | |
T3 | 10.5 (2.9)b | 18.2 (8.4)b | −7.7 [− 13.9 – − 1.5]a | |
PaCO2 (mmHg) | T1 | 42 (4.5) | 42 (5.9) | 0.1 [−5.2–5.4] |
T2 | 41 (6.1) | 43 (4.8) | −2.1 [−8.2–4.1] | |
T3 | 42 (3.3) | 42 (5.1) | −0.3 [−3.8–4.5] | |
pH | T1 | 7.36 (0.05) | 7.34 (0.05) | 0.02 [−0.04–0.08] |
T2 | 7.35 (0.05) | 7.33 (0.05) | 0.01 [−0.04–0.07] | |
T3 | 7.34 (0.05) | 7.35 (0.06) | −0.01 [− 0.06–0.03] | |